Aerocort Inhaler is a medicine that is used for the treatment of Asthma, Wheezing, Shortness Of Breath, Respiratory Disease, Lung Disorder and other conditions.
Aerocort Inhaler contains Beclomethasone, and Salbutamol as active ingredients.
Aerocort Inhaler works by relaxing the muscles in the walls of the small airways in the lungs; making breathing easier by reducing the irritation and swelling of the airways;
Aerocort Inhaler Uses
Shortness Of Breath
Aerocort Inhaler Working, Mechanism of Action and Pharmacology
Relaxing the muscles in the walls of the small airways in the lungs.
Making breathing easier by reducing the irritation and swelling of the airways.
Aerocort Inhaler – Composition and Active Ingredients
Salbutamol (100 MCG)
Beclomethasone (50 MCG)
Aerocort Inhaler – Side-effects
Redness Of The Skin
Tightness In The Chest
Aerocort Inhaler – Precautions & How to Use
Always keep the inhaler upright during the loading of the dose
Always replace the inhaler cap after use
Consult your doctor if you have overactive thyroid gland
Do not use for longer than recommended
Aerocort Inhaler – Drug Interactions
Aerocort Inhaler – Contraindications
Allergic to any ingredient
Eclampsia and severe pre-eclampsia intrauterine infection
Dosage and Administration
Adults and adolescents (12 years and above)
Two inhalations, three or four times daily, titrated to the lowest effective dose.
AEROCORT inhaler may be used with a ZEROSTAT VT Spacer device by patients who find it difficult to synchronize aerosol actuation with inspiration of breath.
Other important Information on Aerocort Inhaler
Missing a dose
In case you miss a dose, take it as soon as you notice. If it is close to the time of your next dose, skip the missed dose and resume your dosing schedule. Do not take extra dose to make up for a missed dose. If you are regularly missing doses, consider setting an alarm or asking a family member to remind you. Please consult your doctor to discuss changes in your dosing schedule or a new schedule to make up for missed doses, if you have missed too many doses recently.
Overdosage of Aerocort Inhaler
Do not take more than prescribed dose. Taking more medication will not improve your symptoms; rather they may cause poisoning or serious side-effects. If you suspect that you or anyone else who may have overdosed of Aerocort Inhaler, please go to the emergency department of the closest hospital or nursing home. Bring a medicine box, container, or label with you to help doctors with necessary information.
Do not give your medicines to other people even if you know that they have the same condition or it seems that they may have similar conditions. This may lead to overdosage.
Please consult your physician or pharmacist or product package for more information.
Storage of Aerocort Inhaler
Store medicines at room temperature, away from heat and direct light. Do not freeze medicines unless required by package insert. Keep medicines away from children and pets.
Do not flush medications down the toilet or pour them into drainage unless instructed to do so. Medication discarded in this manner may contaminate the environment. Please consult your pharmacist or doctor for more details on how to safely discard Aerocort Inhaler.
Expired Aerocort Inhaler
Taking a single dose of expired Aerocort Inhaler is unlikely to produce an adverse event. However, please discuss with your primary health provider or pharmacist for proper advice or if you feel unwell or sick. Expired drug may become ineffective in treating your prescribed conditions. To be on the safe side, it is important not to take expired drug. If you have a chronic illness that requires taking medicine constantly such as heart condition, seizures, and life-threatening allergies, you are much safer keeping in touch with your primary health care provider so that you can have a fresh supply of unexpired medications.
Aerocort Inhaler – Packages and Strengths
Aerocort Inhaler – Packages: 200 mdi
Aerocort Inhaler – Strengths: 100+50
Warnings and Precautions
AEROCORT inhaler is not for use in acute attacks, but for routine long-term management; so, some patients will require a separate levosalbutamol inhaler for relief of acute bronchospasm. For those patients who are steroid-dependent, it is advisable to commence therapy with beclomethasone diproprionate (Beclate Inhaler) as a separate inhaler. Patients who have been weaned in the previous
few months from long-term systemic corticosteroids need special consideration until the hypothalamic pituitary- adrenal system has recovered sufficiently to enable the patient to cope with emergencies such as trauma, surgery or infections. These patients should also be given a supply of oral steroids to use in an emergency when their airways obstruction worsens.
Paradoxical bronchospasm may occur and should be treated immediately with alternative therapy. Need for more doses of levosalbutamol than usual may be a sign of deterioration of asthma and requires re-evaluation of treatment. Cardiovascular effects may occur with beta-adrenergic agonists use. Consider discontinuation of levosalbutamol if these effects occur. Use with caution in patients with underlying cardiovascular disorders. Immediate hypersensitivity reactions may occur. Discontinue levosalbutamol if immediate hypersensitivity reactions occur as demonstrated by racemic salbutamol, such as rare cases of urticaria, angio-oedema, rash, bronchospasm, anaphylaxis, and oropharyngeal oedema. Levosalbutamol should be used with caution in patients with coronary insufficiency, hypertension, and cardiac arrhythmias; in patients with convulsive disorders, hyperthyroidism, or diabetes mellitus; and in patients who are unusually responsive to sympathomimetic amines. Clinically significant changes in systolic and diastolic blood pressure have been seen in individual patients and could be expected to occur in some patients after the use of any beta-adrenergic bronchodilator.
As with other beta-adrenergic agonist medications, levosalbutamol may produce significant hypokalemia in some patients, possibly through intracellular shunting, which has the potential to produce adverse cardiovascular effects. The decrease is usually transient, not requiring supplementation.
Beclomethasone dipropionate is not for use in acute attacks but for routine long term management. Systemic effects may occur with any inhaled corticosteroid, particularly at high doses prescribed for long periods; these effects are much less likely to occur than with oral corticosteroids. Possible systemic effects include Cushing’s syndrome, Cushingoid features, adrenal suppression, growth retardation in children and adolescents, decrease in bone mineral density, cataract and glaucoma and more rarely a range of psychological or behavourial effects including psychomotor hyperactivity, sleep disorders, anxiety, depression or aggression (particularly in children). It is important, therefore, that the dose of inhaled corticosteroid is titrated to the lowest dose at which effective control is maintained. As with all inhaled corticosteroids, special care is necessary in patients with active or quiescent pulmonary tuberculosis. Replacement of systemic steroid treatment with inhaled therapy sometimes unmasks allergies such as allergic rhinitis or eczema previously controlled by the systemic drug. These allergies should be symptomatically treated with antihistamine and/or topical preparations, including topical steroids.
For more information visit us our website: www.medypharma.com